Depending on the type of cancer, the Wnt pathway can be upregulated by different mechanisms, including the overexpression of specific components [71,72], epigenetic dysregulation (e.g., APC promoter hypermethylation [73]), somatic mutations [11] or gene fusions [74]. The gene discussed is APC; the disease is cancer.